z-logo
open-access-imgOpen Access
COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review
Author(s) -
Jessica Jones,
Aiman Faruqi,
James Sullivan,
Cassandra Calabrese,
Leonard H. Calabrese
Publication year - 2021
Publication title -
pathogens and immunity
Language(s) - English
Resource type - Journals
ISSN - 2469-2964
DOI - 10.20411/pai.v6i1.435
Subject(s) - humoral immunity , immunology , immunodeficiency , common variable immunodeficiency , medicine , disease , immunity , confounding , immune system , covid-19 , antibody , infectious disease (medical specialty)
The role of humoral immunity has been well established in reducing infection risk and facilitating viral clearance in patients with COVID-19. However, the relationship between specific antibody responses and severity of COVID-19 is less well understood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom